These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1153559)

  • 1. [Changes in peripheral blood during treatment with some neuroleptics and thymoleptics].
    Kiczak J; Warnecka-Przybylska M; Wdowiak MW
    Psychiatr Pol; 1975; 9(3):275-81. PubMed ID: 1153559
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of some serum enzyme activity in the course of treatment with neuroleptics and thymoleptics].
    Kiczak J; Sliwińska-Przyjemska H; Warnecka--Przybylska M; Wdowiak MW
    Psychiatr Pol; 1976; 10(2):153-7. PubMed ID: 1273160
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of mental disorders in organic diseases with Nobrium].
    Bosshard J
    Praxis; 1969 Jan; 58(4):118-21. PubMed ID: 4891300
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tardive dyskinesia caused by neuroleptics. Survey of 3,140 psychiatric hospital patients].
    Bourgeois M; Tignol J
    Nouv Presse Med; 1977 Nov; 6(39):3649-50. PubMed ID: 607184
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ocular disorders during treatment with neuroleptics and thymoleptics].
    Cuendet JF; Verrey F; Nouri A; Rosselet E; Faggioni R
    Bull Soc Belge Ophtalmol; 1972; 160(2):601-6. PubMed ID: 4656814
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic difficulties in acute surgical abdominal conditions in patients treated with neuroleptics].
    Minta P; Janicki A; Romaniszyn J
    Pol Przegl Chir; 1976 Jul; 48(7):927-31. PubMed ID: 959061
    [No Abstract]   [Full Text] [Related]  

  • 7. [Does the use of neuroleptics and drugs for mood disorders have any special risks in children?].
    Dugas M; Guériot C; Vélin J; Porot D; Calvet S
    Ann Med Interne (Paris); 1972; 123(8):801-4. PubMed ID: 4642197
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extension of therapeutic possibilities by a new tranquilizer].
    Leube H
    Arzneimittelforschung; 1968 Dec; 18(12):1566-8. PubMed ID: 5756250
    [No Abstract]   [Full Text] [Related]  

  • 9. Electroencephalographic variations following anti-psychotic drug treatment. (Diagnostic and prognostic significance).
    Dasberg H; Robinson S
    Dis Nerv Syst; 1971 Jul; 32(7):472-8. PubMed ID: 5570415
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the problem of the terminal extrapyramidal hyperkineses as observed in 1600 patients during long-term therapy with neuroleptics].
    Degkwitz R; Wenzel W; Binsack KF; Herkert H; Luxenburger O
    Arzneimittelforschung; 1966 Feb; 16(2):276-9. PubMed ID: 4861657
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical trial with mesoridazine (another phenodiazine derivative).
    Rudy L; Marozas RJ; Sykes D; Smith JA
    Dis Nerv Syst; 1968 Jun; 29(6):412-3. PubMed ID: 4877749
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic results with a new benzodiazepine derivative].
    Hartl O
    Wien Med Wochenschr; 1971 Feb; 121(8):142-5. PubMed ID: 5313296
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A; Nardini M; Sorgona F
    Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modern developments in the field of neuroleptics and thymoleptics and their meaning in the range of drugs of the DDR].
    Hörig C
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():248-52. PubMed ID: 22887
    [No Abstract]   [Full Text] [Related]  

  • 15. [Delayed-action neuroleptics (sustained-release neuroleptics). Indications, advantages and side effects].
    Predescu V; Nica-Udangiu St
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975; 20(4):287-96. PubMed ID: 1085475
    [No Abstract]   [Full Text] [Related]  

  • 16. [The erythrocyte sedimentation rate (ESR) and treatment with neuroleptics].
    Ibsen KK; Kirk L
    Ugeskr Laeger; 1974 Jul; 136(28):1572-5. PubMed ID: 4210189
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluspirilene, a long-acting injectable neuroleptic.
    Ciccarelli G; Nosé F; Zuanazzi GF
    Acta Psychiatr Belg; 1972 Nov; 72(6):736-47. PubMed ID: 4679675
    [No Abstract]   [Full Text] [Related]  

  • 18. Involuntary movements in a sample of chronic mental patients and their relation to the treatment with neuroleptics.
    Crane GE; Paulson G
    Int J Neuropsychiatry; 1967 Jun; 3(3):286-91. PubMed ID: 4226795
    [No Abstract]   [Full Text] [Related]  

  • 19. The neuroleptics. 11. Epidemiology and sociological aspects.
    Chanoit PF; Collomb H; Kato M; Kristjansen P; Kupka K; Lebedev BA; Lopes JL; Rossi R; Shepherd M; Sivadon P
    Mod Probl Pharmacopsychiatry; 1970; 5():157-63. PubMed ID: 5527164
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medazepam. A new tranquilizer: simple test, intraindividual comparisons and combination therapy].
    Spiegelberg U; Petrilowitsch N; Betz B
    Arzneimittelforschung; 1968 Dec; 18(12):1559-63. PubMed ID: 5756249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.